Calidi Biotherapeutics Inc (CLDI)
2.025
-1.36
(-40.09%)
USD |
NYAM |
Nov 14, 16:00
2.09
+0.06
(+3.21%)
After-Hours: 17:38
Calidi Biotherapeutics Total Liabilities (Quarterly): 18.18M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 18.18M |
| March 31, 2024 | 21.98M |
| December 31, 2023 | 18.25M |
| September 30, 2023 | 19.68M |
| Date | Value |
|---|---|
| June 30, 2023 | 73.89M |
| December 31, 2022 | 53.04M |
| September 30, 2022 | 45.54M |
| December 31, 2021 | 35.00M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
18.18M
Minimum
Jun 2024
73.89M
Maximum
Jun 2023
35.70M
Average
28.49M
Median
Total Liabilities (Quarterly) Benchmarks
| Lumos Pharma Inc | 11.08M |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.431M |
| Shareholders Equity (Quarterly) | -11.75M |